Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11818163rdf:typepubmed:Citationlld:pubmed
pubmed-article:11818163lifeskim:mentionsumls-concept:C0043167lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C0035243lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C0805586lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C1516048lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C0442111lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:11818163lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:11818163pubmed:issue9-10lld:pubmed
pubmed-article:11818163pubmed:dateCreated2002-1-30lld:pubmed
pubmed-article:11818163pubmed:abstractTextThe efficacy of 10 pertussis vaccines prepared from various concentrations of pertussis toxin (PT) and filamentous hemagglutinin (FHA) was investigated in a murine model of respiratory infection (aerosol challenge model) and a murine intracerebral (ic) challenge model. PT was necessary as a vaccine component for protection against an ic challenge with Bordetella pertussis. FHA appeared to play an important role as a vaccine component in protection against an aerosol challenge with B. pertussis. Vaccines containing a small amount of FHA with a large amount of PT (FHA:PT=1:11 or 2:10, w/w) were strongly protective in both the aerosol challenge and the ic challenge models. Ratios of FHA:PT of 1:11 or 2:10 (w/w) might be suitable for future formulations.lld:pubmed
pubmed-article:11818163pubmed:languageenglld:pubmed
pubmed-article:11818163pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:citationSubsetIMlld:pubmed
pubmed-article:11818163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11818163pubmed:statusMEDLINElld:pubmed
pubmed-article:11818163pubmed:monthJanlld:pubmed
pubmed-article:11818163pubmed:issn0264-410Xlld:pubmed
pubmed-article:11818163pubmed:authorpubmed-author:SatoTakaakiTlld:pubmed
pubmed-article:11818163pubmed:authorpubmed-author:WatanabeMineo...lld:pubmed
pubmed-article:11818163pubmed:authorpubmed-author:KomatsuEijiElld:pubmed
pubmed-article:11818163pubmed:authorpubmed-author:AbeKatsuyoKlld:pubmed
pubmed-article:11818163pubmed:authorpubmed-author:IyamaShigehar...lld:pubmed
pubmed-article:11818163pubmed:authorpubmed-author:NagaiMasaakiMlld:pubmed
pubmed-article:11818163pubmed:issnTypePrintlld:pubmed
pubmed-article:11818163pubmed:day31lld:pubmed
pubmed-article:11818163pubmed:volume20lld:pubmed
pubmed-article:11818163pubmed:ownerNLMlld:pubmed
pubmed-article:11818163pubmed:authorsCompleteYlld:pubmed
pubmed-article:11818163pubmed:pagination1429-34lld:pubmed
pubmed-article:11818163pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:meshHeadingpubmed-meshheading:11818163...lld:pubmed
pubmed-article:11818163pubmed:year2002lld:pubmed
pubmed-article:11818163pubmed:articleTitleEfficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model.lld:pubmed
pubmed-article:11818163pubmed:affiliationResearch Center for Biologicals, The Kitasato Institute, 6-111 Arai, Kitamoto, 364-0026, Saitama, Japan.lld:pubmed
pubmed-article:11818163pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11818163lld:pubmed